Acute myeloblastic leukemia, not having achieved remission (2024)

1. ICD-10-CM Codes
›
2. C00-D49
›
3. C81-C96
›
4. C92-
›
5. 2024 ICD-10-CM Diagnosis Code C92.00

Acute myeloblastic leukemia, not having achieved remission

2016 2017 2018 2019 2020 2021 2022 2023 2024 Billable/Specific Code

• C92.00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursem*nt purposes.
• The 2024 edition of ICD-10-CM C92.00 became effective on October 1, 2023.
• This is the American ICD-10-CM version of C92.00 - other international versions of ICD-10 C92.00 may differ.

Approximate Synonyms

• Acute myelocytic leukemia w maturation
• Acute myelocytic leukemia wo maturation
• Acute myeloid leukemia with maturation, fab m2
• Acute myeloid leukemia without maturation, fab m1
• Acute myeloid leukemia, minimal differentiation, fab m0
• Anemia, excess blasts in transformation, refractor
• Leukemia, acute myelocytic, fab m0
• Refractory anemia with excess blasts in transformation (clinical)

Clinical Information

• A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (amls) encompasses four major categories: 1) aml with recurrent genetic abnormalities 2) aml with multilineage dysplasia 3) therapy-related aml 4) aml not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of aml has been recently reduced from 30% (french-american-british [fab] classification) to 20% (who classification). (who, 2001)
• Acute leukemia arising from myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.
• An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.
• Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce neutrophils; basophils; eosinophils; and monocytes.
• Leukemia commonly occurring after alkylating agent treatment; manifestations include pancytopenia, megaloblastic bone marrow, and nucleated red cells in peripheral marrow; patients usually have chromosomal abnormalities in marrow cells.
• leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, however, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In acute myeloid leukemia (aml), there are too many of a specific type of white blood cell called a myeloblast.aml is the most common type of acute leukemia in adults. This type of cancer usually gets worse quickly if it is not treated. Possible risk factors include smoking, previous chemotherapy treatment, and exposure to radiation. Symptoms of aml include:
  • fever
  • shortness of breath
  • easy bruising or bleeding
  • bleeding under the skin
  • weakness or feeling tired
  • weight loss or loss of appetite
  tests that examine the blood and bone marrow diagnose aml. Treatments include chemotherapy, other drugs, radiation therapy, stem cell transplants, and targeted immune therapy. Once the leukemia is in remission, you need additional treatment to make sure that it does not come back. nih: national cancer institute
• This term refers to acute myeloid leukemias that do not fulfill the criteria for inclusion in the group of acute myeloid leukemias which have recurrent genetic abnormalities or myelodysplastic changes, or are therapy-related. It includes entities classified according to the french-american-british classification scheme.

ICD-10-CM C92.00 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

• 820 Lymphoma and leukemia with major o.r. Procedures with mcc
• 821 Lymphoma and leukemia with major o.r. Procedures with cc
• 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
• 834 Acute leukemia without major o.r. Procedures with mcc
• 835 Acute leukemia without major o.r. Procedures with cc
• 836 Acute leukemia without major o.r. Procedures without cc/mcc
• 837 Chemotherapy with acute leukemia as secondary diagnosis or with high dose chemotherapy agent with mcc
• 838 Chemotherapy with acute leukemia as secondary diagnosis with cc or high dose chemotherapy agent
• 839 Chemotherapy with acute leukemia as secondary diagnosis without cc/mcc

Convert C92.00 to ICD-9-CM

Code History

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change
• 2024 (effective 10/1/2023): No change

ICD-10-CM Codes Adjacent To C92.00

Reimbursem*nt claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.